- Home
- BCTX vs GLXG Comparison
BCTX vs GLXG Comparison
Compare BCTX & GLXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCTX
- GLXG
- Stock Information
- Founded
- BCTX 2014
- GLXG 2013
- Country
- BCTX Canada
- GLXG Hong Kong
- Employees
- BCTX N/A
- GLXG N/A
- Industry
- BCTX Biotechnology: Pharmaceutical Preparations
- GLXG
- Sector
- BCTX Health Care
- GLXG
- Exchange
- BCTX Nasdaq
- GLXG NYSE
- Market Cap
- BCTX 15.8M
- GLXG 16.0M
- IPO Year
- BCTX N/A
- GLXG 2024
- Fundamental
- Price
- BCTX $3.85
- GLXG $0.95
- Analyst Decision
- BCTX Strong Buy
- GLXG
- Analyst Count
- BCTX 1
- GLXG 0
- Target Price
- BCTX $32.00
- GLXG N/A
- AVG Volume (30 Days)
- BCTX 45.7K
- GLXG 4.1M
- Earning Date
- BCTX 03-12-2025
- GLXG 05-16-2025
- Dividend Yield
- BCTX N/A
- GLXG N/A
- EPS Growth
- BCTX N/A
- GLXG N/A
- EPS
- BCTX N/A
- GLXG 0.04
- Revenue
- BCTX N/A
- GLXG $3,858,088.00
- Revenue This Year
- BCTX N/A
- GLXG N/A
- Revenue Next Year
- BCTX N/A
- GLXG N/A
- P/E Ratio
- BCTX N/A
- GLXG $21.33
- Revenue Growth
- BCTX N/A
- GLXG N/A
- 52 Week Low
- BCTX $0.35
- GLXG $0.55
- 52 Week High
- BCTX $7.87
- GLXG $16.93
- Technical
- Relative Strength Index (RSI)
- BCTX 50.94
- GLXG N/A
- Support Level
- BCTX $3.44
- GLXG N/A
- Resistance Level
- BCTX $4.36
- GLXG N/A
- Average True Range (ATR)
- BCTX 0.38
- GLXG 0.00
- MACD
- BCTX -0.05
- GLXG 0.00
- Stochastic Oscillator
- BCTX 35.42
- GLXG 0.00
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
About GLXG GALAXY PAYROLL GROUP LTD
Galaxy Payroll Group Ltd provides payroll outsourcing, employment, consultancy, and market research services based in Hong Kong. Its client base includes retail, trading, industrial, IT, financial, and professional services industries. Geographically, the company derives maximum revenue from its clients in the People's Republic of China and the rest from Hong Kong, Macau, Taiwan, Japan, Thailand, Singapore, and other countries.